Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.

IsraelRecruitingPHASE3

Conditions

Metastatic Melanoma · Unresectable Melanoma · Melanoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • University of Alabama at Birmingham: The Kirklin Clinic, Birmingham, Alabama, United States

  • City of Hope, Duarte, California, United States

  • USC Norris Comprehensive Cancer Center, Los Angeles, California, United States

  • California Pacific Medical Center, San Francisco, California, United States

  • University of Colorado Cancer Center, Aurora, Colorado, United States

  • Orlando Health Cancer Institute, Orlando, Florida, United States

  • University of Illinois Hospital & Health Sciences System, Chicago, Illinois, United States

  • University of Kansas, Kansas City, Kansas, United States

  • University of Louisville - James Graham Brown Cancer Center, Louisville, Kentucky, United States

  • National Cancer Institute, Bethesda, Maryland, United States

  • Barbara Ann Karmanos Cancer Hospital dba Karmanos Cancer Center, Detroit, Michigan, United States

  • Henry Ford Health, Detroit, Michigan, United States

  • Dartmouth-Hitchcock Medical Center (DHMC) - Norris Cotton Cancer Center, Lebanon, New Hampshire, United States

  • MD Anderson Cancer Center at Cooper, Camden, New Jersey, United States

  • Oncology Hematology Care, Cincinnati, Ohio, United States

  • Ohio State University, Columbus, Ohio, United States

  • St. Luke's Cancer Center - Anderson, Easton, Pennsylvania, United States

  • Allegheny Health Network, Pittsburgh, Pennsylvania, United States

  • Baptist Cancer Center, Bartlett, Tennessee, United States

  • SCRI Oncology Partners, Nashville, Tennessee, United States

  • Virginia Commonwealth University, Richmond, Virginia, United States

  • Swedish Cancer Institute, Edmonds, Washington, United States

  • Greenslopes Private Hospital, Greenslopes, Queensland, Australia

  • Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia

  • Fiona Stanley Hospital, Murdoch, Western Australia, Australia

  • Flinders Medical Centre, Bedford Park, Australia

  • Westmead Hospital, Westmead, Australia

  • Universitair Ziekenhuis Brussel - Oncologisch Centrum, Jette, Belgium

  • Centre hospitalier de l'Université de Montréal, Montreal, Quebec, Canada

  • Princess Margaret Cancer Centre, Toronto, Canada

  • Institut Paoli Calmettes, Marseille, France

  • Centre Hospitalier Universitaire de Nantes (CHU de Nantes) - Hotel-Dieu, Nantes, France

  • Hopital Saint Louis, Paris, France

  • Charité - Universitätsmedizin Berlin, Berlin, Germany, Germany

  • Universitätsklinikum Carl Gustav Carus, Dresden, Germany

  • Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany

  • Universitätsklinikum Schleswig-Holstein - Campus Lübeck, Lübeck, Germany

  • Klinikum Rechts der Isar der Technischen Universität München, Munich, Germany

  • Hadassah Medical Center, Jerusalem, Israel

  • Sheba Medical Center, Ramat Gan, Israel

  • Tel Aviv Sourasky Medical Center, Tel Aviv, Israel

  • Istituto Romagnolo per lo Studio dei Tumori, Meldola, Forlì-Cesena, Italy

  • Centro di Riferimento Oncologico IRCCS, Aviano, Friuli Venezia Giulia, Italy

  • Istituto Nazionale Per Lo Studio E La Cura Dei Tumori Fondazione Giovanni Pascale, Naples, Napoli, Italy

  • Azienda Ospedaliero Universitaria Pisana, Pisa, Tuscany, Italy

  • Istituto Europeo Di Oncologia, Milan, Italy

  • Azienda Ospedaliera Universitaria Senese, Siena, Italy

  • Nederlands Kanker Instituut, Amsterdam, Netherlands

  • Bundang Medical Center - CHA University, Seongnam-si, Gyeonggi-do, South Korea

  • Samsung Medical Center, Seoul, South Korea, South Korea

  • Korea University Anam Hospital, Seoul, South Korea

  • Seoul National University Hospital, Seoul, South Korea

  • Severance Hospital, Yonsei University Health System, Seoul, South Korea

  • Hospital Universitario Marques de Valdecilla, Santander, Cantabria, Spain

  • Hospital Regional Universitario de Malaga - Hospital General, Málaga, Málaga, Spain

  • Instituto Oncologico Rosell, Barcelona, Spain

  • Hospital Universitari Vall dHebron, Barcelona, Spain

  • Hospital Clinic de Barcelona, Barcelona, Spain

  • ICO l'Hospitalet - Hospital Duran i Reynals, Barcelona, Spain

  • Hospital General Universitario Gregorio Maranon, Madrid, Spain

  • Hospital 12 de Octubre, Madrid, Spain

  • Hospital Universitario Madrid Sanchinarro - CIOCC, Madrid, Spain

  • Hospital Universitario Quirónsalud Madrid, Madrid, Spain

  • Hospital Universitario Ramon y Cajal, Madrid, Spain

  • Clínica Universitaria de Navarra, Pamplona, Spain

  • Hospital Universitario Virgen Macarena, Seville, Spain

  • Consorcio Hospital General Universitario de Valencia, Valencia, Spain

  • Sahlgrenska Universitetssjukhuset, Gothenburg, Västra Götaland County, Sweden

  • Centre Hospitalier Universitaire Vaudois Lausanne, Lausanne, Switzerland

  • Queen Elizabeth Hospital Birmingham, Birmingham, England, United Kingdom

  • Freeman Hospital, Newcastle upon Tyne, England, United Kingdom

  • Royal Marsden Hospital, Chelsea, London, United Kingdom

  • Beaston West of Scotland Canter Centre, Glasgow, United Kingdom

  • Guy's Hospital, London, United Kingdom

  • Sarah Cannon Research Institute UK, London, United Kingdom

Study leads
  • Iovance Biotherapeutics Study Team

    Study Director

    Iovance Biotherapeutics